ReviewJournal of ovarian research2023
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status.
Yongsong Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papercites it